Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen

Journal of Medical Virology

Volumn 84, Issue 2, 2012, Pages 198-206

  Ma, Qiang ^a   Wang, Yefu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Diagnostic problems; HBsAg; Hepatitis B virus (HBV); Therapy failure; Vaccine escape

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ARTICLE; GENETIC HETEROGENEITY; GENOTYPE; HEPATITIS B VIRUS; HYDROPHILICITY; IMMUNOTHERAPY; NONHUMAN; PREVALENCE; VIRUS MUTATION;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; MUTATION; MUTATION RATE;

EID: 83655182788     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23183     Document Type: Article

References (34)

1. Avellon A, Echevarria JM. 2006. Frequency of hepatitis B virus 'a' determinant variants in unselected Spanish chronic carriers. J Med Virol 78:24-36.
2. Bartholomeusz A, Schaefer S. 2004. Hepatitis B virus genotypes: Comparison of genotyping methods. Rev Med Virol 14:3-16.
3. Candotti D, Allain JP. 2009. Transfusion-transmitted hepatitis B virus infection. J Hepatol 51:798-809.
4. Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E, Miceli M, Amiri A, Li C, Allain JP. 2008. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 49:537-547.
5. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R. 1997. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26:1658-1666.
6. Carman WF, Owsianka A, Wallace LA, Dow BC, Mutimer DJ. 1999. Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. J Hepatol 31:195-201.
7. Chotiyaputta W, Lok AS. 2009. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 6:453-462.
8. Coleman PF. 2006. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 12:198-203.
9. Coleman PF, Chen YC, Mushahwar IK. 1999. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 59:19-24.
10. Echevarria JM, Avellon A. 2006. Hepatitis B virus genetic diversity. J Med Virol 78:S36-S42.
11. El Chaar M, Candotti D, Crowther RA, Allain JP. 2010. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 52:1600-1610.
12. Gerlich WH. 2006. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 36:S18-S22.
13. Ho M, Mau Y, Lu C, Huang S, Hsu L, Lin S, Hsu H. 1998. Patterns of circulating hepatitis B surface antigen variants among vaccinated children born to hepatitis B surface antigen carrier and non-carrier mothers. A population-based comparative study. J Biomed Sci 5:355-362.
14. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K. 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34:1027-1034.
15. Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GK, Carman WF. 2000. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31:1176-1182.
16. Jolivet-Reynaud C, Lesenechal M, O'Donnell B, Becquart L, Foussadier A, Forge F, Battail-Poirot N, Lacoux X, Carman W, Jolivet M. 2001. Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies. J Med Virol 65:241-249.
17. Kohno H, Inoue T, Tsuda F, Okamoto H, Akahane Y. 1996. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 77:1825-1831.
18. Lada O, Benhamou Y, Poynard T, Thibault V. 2006. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: Influence of "a" determinant variants. J Virol 80:2968-2975.
19. Laoi BN, Crowley B. 2008. Molecular characterization of hepatitis B virus (HBV) isolates, including identification of a novel recombinant, in patients with acute HBV infection attending an Irish hospital. J Med Virol 80:1554-1564.
20. La'ulu SL, Roberts WL. 2006. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol 125:748-751.
21. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Ferey MP, Ebel A, Dussaix E, Laperche S, Roque-Afonso AM. 2006. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol 44:2321-2326.
22. Panigrahi R, Biswas A, Datta S, Banerjee A, Chandra PK, Mahapatra PK, Patnaik B, Chakrabarti S, Chakravarty R. 2010. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: Implications for transfusion. Virol J 7:204.
23. Qiu S, Zhang J, Tian Y, Yang Y, Huang H, Yang D, Lu M, Xu Y. 2008. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126. Intervirology 51:400-406.
24. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trepo C, Villa E, Will H, Zanetti AR, Zoulim F. 2008. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49:652-657.
25. Roque-Afonso AM, Ferey MP, Ly TD, Graube A, Costa-Faria L, Samuel D, Dussaix E. 2007. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers. Antivir Ther 12:1255-1263.
26. Sayiner AA, Agca H, Sengonul A, Celik A, Akarsu M. 2007. A new hepatitis B virus vaccine escape mutation in a renal transplant recipient. J Clin Virol 38:157-160.
27. Sayiner AA, Ozcan A, Sengonul A. 2008. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus. J Med Virol 80:405-410.
28. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P. 2000. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60:113-121.
29. Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, Yoon JH, Lee HS, Cha CY, Kook YH, Kim BJ. 2005. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol 76:194-202.
30. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599.
31. Tian Y, Xu Y, Zhang Z, Meng Z, Qin L, Lu M, Yang D. 2007. The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 45:2971-2978.
32. Weiss J, Wu H, Farrenkopf B, Schultz T, Song G, Shah S, Siegel J. 2004. Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J Clin Virol 30:86-93.
33. Westhoff TH, Jochimsen F, Schmittel A, Stoffler-Meilicke M, Schafer JH, Zidek W, Gerlich WH, Thiel E. 2003. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 102:1930.
34. Wu C, Zhang X, Tian Y, Song J, Yang D, Roggendorf M, Lu M, Chen X. 2010. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication. J Gen Virol 91:483-4492.